PBIGF
Price
$0.26
Change
+$0.04 (+18.18%)
Updated
May 16 closing price
Capitalization
81.57M
PTCHF
Price
$1.75
Change
+$0.07 (+4.17%)
Updated
Jun 17 closing price
Capitalization
416.65M
Interact to see
Advertisement

PBIGF vs PTCHF

Header iconPBIGF vs PTCHF Comparison
Open Charts PBIGF vs PTCHFBanner chart's image
Paradigm Biopharmaceuticals
Price$0.26
Change+$0.04 (+18.18%)
Volume$1.5K
Capitalization81.57M
PureTech Health
Price$1.75
Change+$0.07 (+4.17%)
Volume$10K
Capitalization416.65M
PBIGF vs PTCHF Comparison Chart in %
Loading...
PBIGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PBIGF vs. PTCHF commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBIGF is a Hold and PTCHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (PBIGF: $0.26 vs. PTCHF: $1.75)
Brand notoriety: PBIGF and PTCHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PBIGF: 52% vs. PTCHF: 423%
Market capitalization -- PBIGF: $77.55M vs. PTCHF: $416.69M
PBIGF [@Biotechnology] is valued at $77.55M. PTCHF’s [@Biotechnology] market capitalization is $416.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBIGF’s FA Score shows that 0 FA rating(s) are green whilePTCHF’s FA Score has 0 green FA rating(s).

  • PBIGF’s FA Score: 0 green, 5 red.
  • PTCHF’s FA Score: 0 green, 5 red.
According to our system of comparison, PTCHF is a better buy in the long-term than PBIGF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBIGF’s TA Score shows that 3 TA indicator(s) are bullish while PTCHF’s TA Score has 2 bullish TA indicator(s).

  • PBIGF’s TA Score: 3 bullish, 2 bearish.
  • PTCHF’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, both PBIGF and PTCHF are a good buy in the short-term.

Price Growth

PBIGF (@Biotechnology) experienced а 0.00% price change this week, while PTCHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +32.93%, and the average quarterly price growth was +6.81%.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTCHF($417M) has a higher market cap than PBIGF($81.6M). PBIGF YTD gains are higher at: -6.207 vs. PTCHF (-12.500).
PBIGFPTCHFPBIGF / PTCHF
Capitalization81.6M417M20%
EBITDA-15.46MN/A-
Gain YTD-6.207-12.50050%
P/E RatioN/A8.33-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
PBIGF vs PTCHF: Fundamental Ratings
PBIGF
PTCHF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9791
PRICE GROWTH RATING
1..100
4461
P/E GROWTH RATING
1..100
10046
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTCHF's Valuation (54) in the null industry is somewhat better than the same rating for PBIGF (90). This means that PTCHF’s stock grew somewhat faster than PBIGF’s over the last 12 months.

PTCHF's Profit vs Risk Rating (100) in the null industry is in the same range as PBIGF (100). This means that PTCHF’s stock grew similarly to PBIGF’s over the last 12 months.

PTCHF's SMR Rating (91) in the null industry is in the same range as PBIGF (97). This means that PTCHF’s stock grew similarly to PBIGF’s over the last 12 months.

PBIGF's Price Growth Rating (44) in the null industry is in the same range as PTCHF (61). This means that PBIGF’s stock grew similarly to PTCHF’s over the last 12 months.

PTCHF's P/E Growth Rating (46) in the null industry is somewhat better than the same rating for PBIGF (100). This means that PTCHF’s stock grew somewhat faster than PBIGF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PBIGFPTCHF
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
44%
Bearish Trend 4 days ago
73%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
45%
Bullish Trend 4 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
35%
Bullish Trend 4 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
33%
Bullish Trend 4 days ago
60%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
47%
Bullish Trend 4 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
PBIGF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEQIX36.980.20
+0.54%
Johnson Equity Income
JIREX11.980.05
+0.42%
JHancock Real Estate Securities 1
TSEMX16.390.05
+0.31%
Touchstone Sands Cptl Emerg Mkts Gr Y
VUIAX88.230.21
+0.24%
Vanguard Utilities Index Adm
LSHCX27.54-0.40
-1.43%
Kinetics Spin-Off and Corp Rest Adv C

PBIGF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBIGF has been loosely correlated with ABEO. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PBIGF jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBIGF
1D Price
Change %
PBIGF100%
N/A
ABEO - PBIGF
34%
Loosely correlated
-2.54%
STTK - PBIGF
21%
Poorly correlated
-8.27%
ARWR - PBIGF
21%
Poorly correlated
+0.06%
OXBDF - PBIGF
7%
Poorly correlated
N/A
PTCHF - PBIGF
6%
Poorly correlated
N/A
More

PTCHF and

Correlation & Price change

A.I.dvisor tells us that PTCHF and PHGE have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTCHF and PHGE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCHF
1D Price
Change %
PTCHF100%
N/A
PHGE - PTCHF
22%
Poorly correlated
-2.22%
BCTX - PTCHF
22%
Poorly correlated
-4.82%
ACET - PTCHF
20%
Poorly correlated
-6.71%
SBMFF - PTCHF
18%
Poorly correlated
N/A
RVXCF - PTCHF
10%
Poorly correlated
-0.33%
More